BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16546741)

  • 1. [Preliminary quantitative study of dynamic magnetic resonance diffusion tensor imaging in rabbit models implanted with hepatic tumor grafts from VX2].
    Xu SB; Quan XY; Sun XJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):335-8. PubMed ID: 16546741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quantitative study of dynamic magnetic resonance perfusion-weighted imaging in rabbit models of implanted hepatic VX2 tumor].
    Quan XY; Zhang XL; Sun XJ; Xing HF; Liang W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):620-2. PubMed ID: 16762866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-course studies of implanted rabbit VX2 liver tumors to identify the appropriate time for starting hepatic arterial embolization in animal models.
    Sonoda A; Nitta N; Nitta-Seko A; Ohta S; Nagatani Y; Mukaisho K; Otani H; Tsuchiya K; Takahashi M; Murata K
    Oncology; 2011; 80(1-2):92-6. PubMed ID: 21677452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between MR diffusion weighted imaging with malignant degree of rabbit liver VX2 tumor models].
    Wang JP; Bai RJ; Sun HR; Zhao X; Li YJ; Yang J
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(31):2210-3. PubMed ID: 20058602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted magnetic resonance imaging to evaluate microvascular density after transarterial embolization ablation in a rabbit VX2 liver tumor model.
    Qian T; Chen M; Gao F; Meng F; Gao X; Yin H
    Magn Reson Imaging; 2014 Oct; 32(8):1052-7. PubMed ID: 24970024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted MR: therapeutic evaluation after chemoembolization of VX-2 carcinoma implanted in rabbit liver.
    Youn BJ; Chung JW; Son KR; Kim HC; Jae HJ; Lee JM; Song IC; Kim IO; Park JH
    Acad Radiol; 2008 May; 15(5):593-600. PubMed ID: 18423316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
    Fan WJ; Zhang L; Ouyang YS
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2474-7. PubMed ID: 19080627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The experimental study of magnetic resonance diffusion-weighted imaging to the treatment of acute hepatic injury with allogeneic MBMCs transplantation into liver].
    Shang QL; Xiao EH; Zhou QC; Wu HJ
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(7):491-5. PubMed ID: 21418983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo diffusion-weighted imaging of liver tumor necrosis in the VX2 rabbit model at 1.5 Tesla.
    Deng J; Rhee TK; Sato KT; Salem R; Haines K; Paunesku T; Mulcahy MF; Miller FH; Omary RA; Larson AC
    Invest Radiol; 2006 Apr; 41(4):410-4. PubMed ID: 16523024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamic evaluation of rabbit VX2 hepatic carcinoma with CT and MRI].
    Jia HS; Quan XY; Zeng S; Wen ZB
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):141-4. PubMed ID: 12390810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted MR imaging allows monitoring the effect of combretastatin A4 phosphate on rabbit implanted VX2 tumor model: 12-day dynamic results.
    Shao H; Ni Y; Dai X; Zhang J; Chen F; Fan G; Sun Z; Li Y; Zhou H; Xu K
    Eur J Radiol; 2012 Mar; 81(3):578-83. PubMed ID: 21454029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
    Kamel IR; Bluemke DA; Eng J; Liapi E; Messersmith W; Reyes DK; Geschwind JF
    J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of VX2 carcinoma in rabbit tibia: magnetic resonance imaging with pathologic correlation.
    Choi JA; Kang EY; Kim HK; Song IC; Kim YI; Kang HS
    Clin Imaging; 2008; 32(2):128-35. PubMed ID: 18313577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
    Rhee TK; Naik NK; Deng J; Atassi B; Mulcahy MF; Kulik LM; Ryu RK; Miller FH; Larson AC; Salem R; Omary RA
    J Vasc Interv Radiol; 2008 Aug; 19(8):1180-6. PubMed ID: 18656011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion tensor magnetic resonance imaging of prostate cancer.
    Manenti G; Carlani M; Mancino S; Colangelo V; Di Roma M; Squillaci E; Simonetti G
    Invest Radiol; 2007 Jun; 42(6):412-9. PubMed ID: 17507813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
    Buijs M; Kamel IR; Vossen JA; Georgiades CS; Hong K; Geschwind JF
    J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of VX2 rabbit hepatoma models and modification of the hepatic artery catheterization technique].
    Zhong L; Yu ZJ; Quan XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1654-6, 1659. PubMed ID: 18819892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted multiparametric MRI for monitoring longitudinal changes of parameters in rabbit VX2 liver tumors.
    Wu H; Liu H; Liang C; Zhang S; Liu Z; Liu C; Liu Y; Hu M; Li C; Mei Y
    J Magn Reson Imaging; 2016 Sep; 44(3):707-14. PubMed ID: 26878263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.
    Kamel IR; Reyes DK; Liapi E; Bluemke DA; Geschwind JF
    J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):49-56. PubMed ID: 17296704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravoxel incoherent motion diffusion-weighted MR imaging for monitoring the therapeutic efficacy of the vascular disrupting agent CKD-516 in rabbit VX2 liver tumors.
    Joo I; Lee JM; Han JK; Choi BI
    Radiology; 2014 Aug; 272(2):417-26. PubMed ID: 24697148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.